Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets

  • 1, 2, 3,
  • 2, 4,
  • 5,
  • 6,
  • 4,
  • 7, 8,
  • 9,
  • 10, 11Email author and
  • 12, 13
DARU Journal of Pharmaceutical Sciences201826:230

https://doi.org/10.1007/s40199-018-0230-4

  • Published:

The original article was published in DARU Journal of Pharmaceutical Sciences 2018 26:222

Correction to: DARU J Pharm Sci

https://doi.org/10.1007/s40199-018-0222-4

The corresponding author, Mohammad Hosein Farzaei, affiliation is Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. The correct spelling of the 7th author surname is Iranpanah. The full reference for 18, 33, 59, 64 and 66 is as follows:

18. Sun Q, Luan L, Arif M, Li J, Dong Q-J, Gao Y, et al. Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases. Carbohydrate Polymers. 2018;189:352–359.

33. Zangabad PS, Mirkiani S, Shahsavari S, Masoudi B, Masroor M, Hamed H, et al. Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications. Nanotechnology Reviews. 2018;7(1):95–122.

59. Tamura A, Ozawa K, Ohya T, Tsuyama N, Eyring EM, Masujima T. Nanokinetics of drug molecule transport into a single cell. Nanomedicine (Lond). 2006,1(3):345–350.

64. Koopaei NN, Abdollahi M. Opportunities and obstacles to the development of nanopharmaceuticals for human use. DARU Journal of Pharmaceutical Sciences; 2016,24(1): 23.

66. Mostafalou S, Mohammadi H, Ramazani A, Abdollahi M. Different biokinetics of nanomedicines linking to their toxicity; an overview. DARU Journal of Pharmaceutical Sciences; 2013.21(1): 14.

Notes

Authors’ Affiliations

(1)
Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
(2)
PhytoPharmacology Interest Group (PPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
(3)
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
(4)
Department of Pharmacy in Persian Medicine, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran
(5)
Oswaldo Cruz Foundation (FIOCRUZ), Institute of Technology in Pharmaceuticals (Farmanguinhos), Rio de Janeiro, RJ, Brazil
(6)
Internal Medicine Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
(7)
Department of Chemistry, Sharif University of Technology, Tehran, Iran
(8)
PhytoPharmacology Interest Group (PPIG), Universal Scientific Education and Research Network (USERN), Los Angeles, CA, USA
(9)
Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
(10)
Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
(11)
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
(12)
Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
(13)
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Copyright

© Springer Nature Switzerland AG 2018

Advertisement